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Purpose of review 
Basophils and eosinophils respectively represent less than 1 and 5% of white blood cells 
respectively. Their role in asthma and allergic inflammation remains incompletely defined. 
The present review addresses recent advances regarding the role of these two cell populations 
in allergic inflammation and asthma regarding both biological and genetic point of view. 
Recent findings 
Regarding eosinophils, the role of interleukin(IL)-25, IL-33 and thymic stromal 
lymphoprotein (TSLP) have been evidenced, and activation states of eosinophil Beta1 and 
Beta2 integrins have been found to correlate with measurement of eosinophil recruitment and 
pulmonary function in asthma. New insights in the biology of basophils concern their role as 
regulators of Th2 cell response through IL-4 expression or the differentiation of monocytes to 
macrophages, and their population heterogeneity in human. The transcription factor PU.1 was 
reported to be involved in controlling transcription of specific genes both in eosinophils and 
basophils. Candidate genetic studies on eosinophils have explored genes involved in the 
intracellular calcium influx and apoptosis. At the genome-wide level, studies identified 
genetic variants belonging to IL1RL1, TSLP and IL-33, and four loci with pleiotropic effects 
on eosinophil and basophil counts (GATA2 (3q21), MHC (6p21), HBS1L-MYB (6q23), and 
ERG (21q22)). 
Summary 
Recent findings from biological and genetic studies on eosinophils and basophils highlight the 
role of epithelial cell-derived cytokines such as TSLP and IL-33 in asthma and allergic 
diseases.  
Keywords 
basophil, eosinophil, allergy, asthma, TSLP, IL-33, IL-25, integrins
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INTRODUCTION 
Blood granulocytes are divided in three subsets: basophils, eosinophils and neutrophils. Both 
basophils and eosinophils are involved in allergic inflammation, and circulate at relatively low 
levels in the blood, making-up 0.1-1% and 1-5% of white blood cells respectively. 
The contribution of basophils and eosinophils to allergic inflammation remains incompletely 
defined. Although described by Paul Ehrlich in 1879 and conserved in all vertebrates, 
including fish, birds and reptiles, the in vivo role of basophils is always elusive and was 
poorly investigated, and therefore sometimes considered as possibly redundant "circulating 
mast cells" [1]. In recent years, basophils have been considered as primary effector cells in 
allergic disorders such as asthma, hay fever and anaphylaxis. In contrast, extensive studies on 
eosinophils have revealed their contribution to host defense, immunomodulation, tissue 
remodeling and fibrosis, and in immunoregulatory and anti-inflammatory processes. 
Activation of eosinophils in asthmatic patients causes inflammation, airway remodeling, 
mucus production and airway hyperreactivity. The recruitment of eosinophils is related to the 
release of cytokines, chemokines and others products such as IL-3, IL-4, IL-5, IL-13, CCL11, 
CCL24, CCL26, TNFα, integrins, and histamine, released from different cells involved in the 
disorders (see Figure 1) [2].  Basophils may be recruited to sites of inflammation especially 
during immune responses against allergens and contribute to hypersensitivity reactions. 
Basophils are also known as regulators of Th2 responses in allergic inflammation and can 
play a role of antigen-presenting cells (APCs). 
Many publications have been published on both the role of cytokines and other mediators in 
all aspects of eosinophil development, activation and survival, and cellular features of 
eosinophils. In contrast, the literature on basophils is scarce, and this imbalance is reflected in 
this review which focuses on the new insights of the role of basophils and eosinophils in 
allergic inflammation according to both biological and genetic findings in the last 18 months.  
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In the first part of the review we highlight the role of three new epithelial cell-derived 
cytokines in the activation of eosinophils and basophils, then we discuss recent advances in 
biology regarding attraction, adhesion, migration and proliferation of eosinophils, the role of 
basophils in Th2 cell responses, the heterogeneity between basophil populations, and the 
similarity between the regulation of eosinophils and basophils. Published data relevant to the 
research of the genetic of eosinophils and basophils is discussed in the third part of this 
review. 
NEW INSIGHTS IN THE BIOLOGY OF EOSINOPHILS  
Recent literature highlights the role of epithelial cell-derived cytokines in the activation of 
eosinophils and reported new findings on the attraction, adhesion, migration and proliferation 
of eosinophils.  
The role of the airway epithelial cells 
Airway epithelial cells represent the first line of defense against allergens and various 
particles. Activation of the cells is a key triggering event in the recognition of inhaled 
allergens that activates the network of dendritic cells (DCs) to promote Th-2 immunity. 
Epithelial-derived cytokines and chemokines also activate innate immune cells such as 
basophils, mast cells, eosinophils and neutrophils [3]. More recent studies indicate an 
immunologic function of airway epithelium. A triad of cytokines, including interleukin (IL)-
25, IL-33 and Thymic stromal lymphoprotein (TSLP) - a cytokine associated with the 
development of multiple allergic disorders - is released by airway epithelial cells in response 
to various environmental factors (see Figure 1) [4]. 
IL-25 is produced by activated Th2 cells, epithelial cells and mast cells. IL-25 provokes the 
production of Th2 type cytokines (including IL-5) from Th2 cells and subsequently amplify 
the recruitment and survival of eosinophils in allergic patients. High expression of both IL-25 
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and the IL-25 receptor has been detected in a recent study of bronchial and skin biopsies from 
allergic patients [5].  
IL-33 has the potential to induce Th2 cytokine-mediated allergic inflammation. IL-33 is 
implicated in asthma, allergic conjunctivitis and anaphylactic responses. It has been shown 
that IL-33 is an essential biomarker in the development of ragweed-induced allergic rhinitis in 
mice [6] because ragweed-immunized and ragweed-challenged IL-33 -/- mice showed a 
significant reduction in the frequency of sneezing, total and ragweed-specific response, and 
accumulation of eosinophils and basophils in the nasal mucosa [6]. In a mouse model of 
allergic asthma, pretreatment with anti IL-33 results in decreases of serum IgE, eosinophils in 
broncho-alveolar fluid (BALF), eosinophilic infiltration into the lung and decreased airway 
hyperresponsiveness [7].  
TSLP, member of the IL-2 family, is mainly synthesized from epithelial cells but also from 
basophils and mast cells. Overexpression of TSLP in mice caused a weak innate response and 
was insufficient for development of airway inflammation. On the contrary, both 
overexpression of TSLP and antigen challenge provoke airway eosinophilia and airway 
remodeling in a mice model [8]. TSLP seems to play an important role in Th2-type immune 
responses and airway inflammation likely through mechanisms involving the interface 
between the innate and adaptive immunity and/or adaptive immunity itself [8]. Some recent 
publications concerning the role of TSLP are mainly focused on atopic dermatitis, and 
infection diseases. 
Attraction of eosinophils in the airways and in the skin 
Members of the eotaxin subfamilies are well-known to have a major chemotactic role for 
eosinophils. Recent advances in this field are the significant correlation shown between the 
level of the chemokine (C-C motif) ligand 24 (CCL24)/eotaxin 2 and the degree of 
eosinophilia and clinical symptoms in patients with rhinitis or with allergy [9]. Expression of 
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CCL24 in the nasal mucosa of allergic and asthmatic patients was significantly increased as 
compared to control and COPD groups [9]. Furthermore, the up-regulation of CCL26/eotaxin 
3 was also enhanced in patients with seasonal allergic rhinitis leading to an increase of 
eosinophils in the nasal mucosa and probably in the airway walls of the lower respiratory tract 
[9]. Since skin eosinophil infiltration is one of the most important characteristics of atopic 
dermatitis, Bao et al. studied in detail the signal transduction pathway for IL-4 regulation of 
CCL26  in human immortalized keratinocytes [10]. They showed that the regulation is at the 
transcriptional level and involves the Janus kinase(jak)1 and Jak2/signal transducer and 
activator of transcription (Stat)6 pathway.  
Adhesion, migration and proliferation of eosinophils in the mucosa 
Recent papers focused on galectin-3 (Gal-3) and integrins. Gal-3, a β galactoside binding 
lectin, is implicated in the pathogenesis of allergic airway inflammation. Gal-3 -/- mice 
exposed to chronic allergen (OVA) challenge have attenuated airway eosinophilia and exhibit 
less severe remodeling of the airways [11]. Furthermore, airway eosinophilia in acute and 
chronic allergen-challenged mice was accompanied with elevated levels of extracellular 
soluble Gal-3 in the BALF and intracellular Gal-3 in the lung tissue [11]. Gal-3 is secreted by 
various cell types such as macrophages and activated Th2 cells, but also by eosinophils 
especially when exposed to eotaxin-1. Secreted Gal-3 can bind to integrin and other glycan 
ligand on all the surface of human eosinophils to facilitate all trafficking and activation in 
allergic airway. 
Arrest of eosinophils in vessels and their extravasation into the airway wall are partially 
mediated by the integrin family of cell adhesion receptors. Recent papers highlight for the 
first time the influence of different conformations of integrins on eosinophils trafficking. 
Studies in mice and human indicate that α4β1 and αMβ2 are the major eosinophil integrins 
mediating cell adhesion with α4β1 largely responsible for arrest of blood eosinophils on 
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vascular cell adhesion molecule-1 (VCAM-1) in vessels of the asthmatic lung whereas 
activated αMβ2 by interacting with periostin and possibly other ligands, is involved in 
subsequent eosinophil recruitment and persistence in the extracellular matrix of the bronchi of 
asthma [12-14].  Cellular feature of eosinophils 
New insights into immunity and Th2 immune responses were provided through a better 
understanding of the physiological roles of IL-5, which is produced by eosinophils and 
involved in many aspects of eosinophil development. Ikutani et al. [15] used a generation of 
IL-5/Venus knockin mice to identify innate IL-5-producing lymphoid cells that play a role in 
orchestrating eosinophil responses in the lung. They found unique tissue localization of innate 
IL-5-producing cells in the lungs of untreated mice; these cells regulate eosinophil infiltration 
into the lung, and may contribute to antitumor immunity via lung eosinophils.  
IL-17 is an important cytokine of the T helper 17 pathway. It has been suggested that in the 
lung, IL-17 could be involved in the neutrophilic inflammation and airway remodeling of 
chronic respiratory diseases [16]. Eosinophils can promote IL-17 production through the 
release of IL-1β and modulates the allergic airway inflammation in asthma [17]. 
NEW INSIGHTS IN THE BIOLOGY OF BASOPHILS 
Recent findings in the biology of basophils focus on their role in the regulation of Th2 cell 
response through IL-4 expression, in the differentiation of monocytes to macrophages, and on 
their population heterogeneity in human.  
Basophils and Th2 cell responses  
The apparent contradictions between different studies on the possibilities of basophils to act 
as APCs probably come from the nature and type of antigen presented and the route of 
antigens administration. Basophils alone were reported to polarize T cells towards Th2 for 
haptens and peptides antigens but needed the presence of DCs for protein antigens [18,19]. 
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However, a basophil requirement for IL-4 production by naïve CD4+ T cell was not observed 
in novel reporter strains of mice following a papain-induced model of allergy [20]. In a very 
recent study, correlation between the numbers of basophils in the lungs tissues with IgE-
associated airway allergic inflammation was reported in OVA-immunized mice, and purified 
pulmonary basophils from these mice were functional and amplified Th2 responses [21]. 
Furthermore, in vitro, lung basophils failed to initiate Ag-specific naïve or OVA-immunized 
but were able to cooperate with DCs to increase Ag-specific Th2 cell differentiation and to 
increase local Th2 response via IL-4-dependent and IL-4 independent mechanisms. Overall, 
both in vivo and in vitro, in humans as in mice, human basophils seem to enhance IL-4 
expression by interacting directly with CRTH2+ CD4 effector, circulating memory Th2 cells.. 
On the other hand, an unexpected interaction between basophils and monocytes-macrophages 
was observed during allergic skin inflammation [22]. The fate, polarization and function of 
monocytes after their recruitment to skin lesions were analyzed under an immunoglobulin E-
mediated chronic allergic inflammation (IgE-CAI), a model where basophils play a critical 
role. Basophils promoted the differentiation of inflammatory monocytes into M2 
(alternatively activated) macrophages rather than M1 (classically activated) macrophages, 
being from proinflammatory to anti-inflammatory. By using new genetic tools, inflammatory 
monocytes were showed to acquire an M2-like phenotype through IL-4R in response to 
basophil-derived IL-4, and to exert an anti-inflammatory function to regulate the allergic 
inflammation. Furthermore, TSLP produced by basophils amplified the M2 polarization in 
allergic airway inflammation [23]. These findings bring new light on the role of basophils as 
regulators of allergic skin inflammation. 
Heterogeneity in basophils 
Whereas IL-3 is considered as essential for basophil activation, expansion and survival TSLP 
was recently reported to promote peripheral basophilia in both IL-3/IL-3-R- sufficient and 
9 
 
deficient environments, and to contribute to Th2 cytokine responses in vivo (see Figure 1) 
[24]. Furthermore, genome-wide transcriptional profiling and functional analyses identified 
phenotypic heterogeneity, distinct responsiveness and functional potential between TSLP- 
versus IL-3-elicited basophils. This heterogeneity in human basophil populations correlated 
with susceptibility to allergic inflammation [24]. 
EOSINOPHIL AND BASOPHIL: WHAT DO THEY SHARE? 
Eosinophil development is determined by the interplay of a few transcription factors including 
PU.1, a member of the Ets (E-twenty six) transcription family, one of the largest families of 
transcription factors which have a conserved Ets domain that belongs to the winged helix-
turn-helix DNA-binding domain superfamily. PU.1 is involved in controlling transcription of 
eosinophil-specific genes such as MPB (major basic protein), EDN (ribonuclease, RNase A 
family, 2), ECP (ribonuclease, RNase A family, 3), EPO (erythropoietin), CCR3 (chemokine 
(C-C motif) receptor 3) and IL-5R (Interleukin 5 receptor, alpha) [25]. PU.1 seems to have the 
same role in basophils since it was also involved in the transcriptional activity of the ST2 
promoter - the Interleukin 1 receptor-like 1 gene (IL1RL1/ST2) encodes IL-33 receptor - 
bound to its promoter region, and participated to its expression in human basophilic cell line 
[26]. 
Finally, because little is known about the mechanism of cooperative function between 
basophils and eosinophils in immunoglobulin E-mediated chronic allergic inflammation (IgE-
CAI), Matsuoka et al. [27] generated new basophil- and eosinophil-depletion mouse models 
(basophil diphtheria toxin receptor (basoDTR) and eosinophil (Eo)DTR mice respectively). 
As said by the authors, the basoDTR mice model will permit to measure the cellular dynamics 
of basophils, and the EoDTR mice is the first model for conditional eosinophil ablation in 
vivo. 
GENETIC STUDIES OF EOSINOPHIL AND/OR BASOPHIL COUNTS 
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The recent genetic findings at both the candidate and the genome-wide levels are now 
discussed. The main new results in candidate genetic studies are the genes involved in the 
intracellular calcium influx and apoptosis in eosinophils. At the genome-wide level, studies 
identified genetic variants related to the triade of cytokines that we described in the first 
subsection.  
Candidate association studies  
Eosinophils and basophils are known to be heritable traits with heritability estimate ranged 
from 14% for basophils to 30-35% for eosinophil counts [28,29]. To our knowledge, no 
association between genes and basophil counts or percent was investigated at a candidate 
level. Recent studies on eosinophils have explored genes in two pathways involved in the 
cellular response which are the intracellular calcium influx and apoptosis. Following the 
establishment of the importance of the 17q12-21 locus in asthma, which includes the 
gasdermin B (GSDMB)/ORM1-like 3 (ORMDL3) genes, Kang et al. [30] investigated the 
association between polymorphisms in these genes, whose ORMDL3 protein binds to and 
inhibits the calcium pump in the sarco-endoplasmic reticulum, and blood eosinophils 
expressed as percent in 1907 elementary school Korean children. Eosinophils were 
significantly lower in subjects carrying the A allele of rs4794820 and with a methacholine 
provocation test value ≤ 16, showing for the first time that polymorphisms in the 
GSDMB/ORMDL3 genes may affect eosinophil-mediated bronchial hyperresponsiveness. 
Another interesting but intriguing result is the association of the 
rs2238634T/rs2238633G/rs2238632T/rs2238631A haplotype in the thromboxane A2 receptor 
gene (TBXA2R), member of the seven-transmembrane G-protein-coupled receptor super 
family, and blood eosinophils in 226 childhood-onset asthma patients and 164 controls from 
Japan: homozygotes for this haplotype had higher levels of blood eosinophils than other 
zygotes in female controls, whereas a trend for lower levels of blood eosinophils was found in 
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female asthma patients. No association was reported in male whatever the asthma status [31]. 
Furthermore, this haplotype was associated with lower lung function in asthma patients, and 
with increased TBXA2R mRNA level, suggesting severe airway inflammation and/or 
remodeling in these subjects. The last study [32] investigated association between Baculoviral 
IAP repeat containing 5 (BIRC5, also called survivin), a member of the inhibitor of apoptosis 
protein family and blood eosinophils in a case-control study (307 asthma /344 control 
Hungarian subjects). The authors found that individuals homozygous for the wild-type allele 
of rs9904341 had elevated eosinophil levels compared to those carrying either one or two 
copy of the rare allele. This result was confirmed by haplotype analysis, and was coherent 
with the elevated BIRC5 mRNA levels found in sputum samples of patients with asthma as 
compared to controls, and the correlation between sputum eosinophil and BIRC5 mRNA 
levels, suggesting that survivin may have a primordial role in eosinophil accumulation. 
Overall, these finding highlight the interest to study several genes in metabolic pathway such 
as regulation of calcium influx and apoptotic response to better understand the contribution of 
eosinophils in allergic inflammation.  
Genome-wide association studies 
Three genome-wide association studies (GWAS) of eosinophil and/or basophil cell counts 
have been conducted in European and Asian populations [33-35]. These GWAS led to 
detection of four loci with pleiotropic effect on eosinophil and basophil counts in both 
European and Asian samples: GATA2 (GATA binding protein 2, 3q21), MHC region (major 
histocompatibility complex, 6p21), HBS1L-MYB (HBS1-like - myeloblastosis viral oncogene 
homolog, 6q23), and ERG (erythroblastosis virus E26 oncogene homolog, 21q22) [33,35]. 
Three other regions showed association with basophil count: SLC45A3-NUCKS1 (solute 
carrier family 45, member 3 - nuclear casein kinase and cyclin-dependent kinase substrate 1, 
1q32), RPN1-C3orf27 (ribophorin I - chromosome 3 open reading frame 27, 3p21), and 
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NAALAD2 (N-acetylated alpha-linked acidic dipeptidase 2, 11q14) [34,35]. The first GWAS 
of eosinophils identified six other regions associated with eosinophil counts in European 
populations: IL1RL1 (2q12), IKZF2 (IKAROS family zinc finger 2, 2q13), WDR36 (WD 
repeat domain 36, 5q22), IL5 (interleukin 5, 5q31), IL33 (interleukin 33, 9p24), and SH2B3 
(SH2B adaptor protein 3, 12q24) [33]. Interestingly, in this study, the genetic variants in 
IL1RL1, WDR36 and IL33, that were associated first with eosinophil count, were also 
associated with asthma and atopic asthma [33]. Moreover, a GWAS of eosinophilic 
esophagitis (a food allergy-related disorder characterized by the accumulation of eosinophils 
in the esophagus) identified genetic variants belonging to TSLP-WDR36 locus among the 
most significant SNPs associated with the disease [36]. Candidate gene studies of IL33, TSLP 
and IL1RL1 as well as GWAS of asthma and asthma-related phenotypes have further 
implicated these loci in asthma and atopy susceptibility. 
CONCLUSION 
In the last years, the immunological approach has considerably developed the understanding 
of the cellular mechanisms of asthma and allergy. One could ask if allergy is really an 
immunological disease? and asthma a genetic disorder affecting the bronchial smooth muscle? 
The eosinophils play a key role in allergic inflammation but other cells such as basophils are 
still poorly known to be involved in the pathway leading to the inflammatory reaction. A lot 
of extensive studies have been done in mice to better understand the underlying 
immunological mechanisms, but very few papers have investigated the human cells. Novel 
genetic tools are developed in mice models to elucidate the role of basophils in vivo. It is 
difficult to anticipate if the results will reflect some functional significances similar as those 
in humans. Furthermore, the large number of different clinical phenotypes observed in asthma 
and allergy complicates the understanding of the immunological mechanisms.  
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The genetic studies highlight the importance of epithelial cell-derived cytokines (TSLP and 
IL-33) that promote differentiation and activation of Th2 cells and their receptors (IL1RL1 
encodes ST2, the receptor for IL-33 on immune cells including mast cells, Th2 cells, T 
regulatory cells). Replication of genetic results is often difficult due to the disparity in 
phenotype definition. A pathway-based approach where several genes are selected for 
analysis, based on biological knowledge, can represent a good strategy to detect relevant 
associations with eosinophils or basophils, and better understand their role in allergic 
inflammation.
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Key bullet points  
 
Key bullet point 1: New epithelial cell-derived cytokines, including IL-25, IL-33 and TSLP 
activate innate immune cells such as basophils and eosinophils. 
Key bullet point 2: Galectin-3 and different conformations of integrins regulate trafficking 
and activation of eosinophils in allergic airways. 
Key bullet point 3: Acting as antigen-presenting cells for haptens and peptide antigens, 
basophils interact with Th2, monocytes and macrophages, thus taking an ever increasingly 
importance in the regulation of the allergic skin inflammation. 
Key bullet point 4: Biological and genetic studies highlight the role of epithelial cell-derived 
cytokines (TSLP and IL-33) that promote differentiation and activation of th2 cells and their 
receptors. 
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Figure. 1. Cascade of events involving eosinophils and basophils related to immunological 
responses in allergy. The cellular mechanisms of asthma and allergy are complex in the 
bronchial mucosa. Many mediators are released inducing smooth muscle contraction and local 
inflammation. Epithelial cell activation by inhaled allergen activates the local network of 
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dendritic cells which promote Th2 immune responses. Among the cytokines released by 
epithelial cells, IL-25, IL-33 and TSLP seem to play an important role in in the pathway 
leading to the inflammatory reaction. For example, TSLP promotes the growth and 
differentiation of basophils from the bone marrow whereas IL-25 and IL-33 enhance Th2 
development that mainly produce IL-5 and IL-13 and contribute to eosinophilic inflammation. 
16 
 
REFERENCES AND RECOMMENDED READING 
Papers of particular interest, published within the annual period of review, have been 
highlighted as: 
* of special interest 
** of outstanding interest 
Additional references related to this topic can also be found in the Current World Literature 
section in this issue (pp. xx–xx). 
1. Falcone FH, Haas H, Gibbs BF. The human basophil: a new appreciation of its role in 
immune responses. Blood 2000; 96:4028-4038. 
2. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. 
Nat Rev Drug Discov 2013; 12:117-129. 
3*. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18:684-
692. 
The review clearly shows that the airway epithelium controls many aspects of allergic 
sensitization and play an important role in allergic inflammation, remodeling and 
hyperreactivity. Thus, the epithelial cells are involved in the immunological pathways. 
4*. Bartemes KR, Kita H. Dynamic role of epithelium-derived cytokines in asthma. Clin 
Immunol 2012; 143:222-235. 
The airway epithelium play an important role in driving Th2 type immune response and 
chronic airway inflammation. New epithelial cell-derived cytokines, including IL-25, IL-33 
and TSLP are implicated in Th2-type immune responses. 
5. Corrigan CJ, Wang W, Meng Q, et al. Allergen-induced expression of IL-25 and IL-25 
receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy 
Clin Immunol 2011; 128:116-124. 
17 
 
6. Haenuki Y, Matsushita K, Futatsugi-Yumikura S, et al. A critical role of IL-33 in 
experimental allergic rhinitis. J Allergy Clin Immunol 2012; 130:184-194 e111. 
7. Cho KA, Suh JW, Sohn JH, et al. IL-33 induces Th17-mediated airway inflammation via 
mast cells in ovalbumin-challenged mice. Am J Physiol Lung Cell Mol Physiol 2011; 
302:L429-440. 
8. Headley MB, Zhou B, Shih WX, et al. TSLP conditions the lung immune environment for 
the generation of pathogenic innate and antigen-specific adaptive immune responses. J 
Immunol 2009; 182:1641-1647. 
9. Paplinska M, Hermanowicz-Salamon J, Nejman-Gryz P, et al. Expression of eotaxins in the 
material from nasal brushing in asthma, allergic rhinitis and COPD patients. Cytokine 
2012; 60:393-399. 
10. Bao L, Shi VY, Chan LS. IL-4 regulates chemokine CCL26 in keratinocytes through the 
Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis. Mol 
Immunol 2012; 50:91-97. 
11. Ge XN, Ha SG, Liu FT, et al. Eosinophil-expressed galectin-3 regulates cell trafficking 
and migration. Front Pharmacol 2013; 4:37. 
12. Johansson MW, Gunderson KA, Kelly EA, et al. Anti-IL-5 attenuates activation and 
surface density of beta(2) -integrins on circulating eosinophils after segmental antigen 
challenge. Clin Exp Allergy 2013; 43:292-303. 
13*. Johansson MW, Mosher DF. Integrin activation States and eosinophil recruitment in 
asthma. Front Pharmacol 2013; 4:33. 
This is an important work that demonstrates that activation states of eosinophil β1 and β2 
integrins correlate with measurements of eosinophil recruitment and pulmonary function in 
asthma. 
18 
 
14. Masuoka M, Shiraishi H, Ohta S, et al. Periostin promotes chronic allergic inflammation 
in response to Th2 cytokines. J Clin Invest 2012; 122:2590-2600. 
15. Ikutani M, Yanagibashi T, Ogasawara M, et al. Identification of innate IL-5-producing 
cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol 
2012; 188:703-713. 
16. Tan HL, Rosenthal M. IL-17 in lung disease: friend or foe? Thorax 2013. 
17. Esnault S, Kelly EA, Nettenstrom LM, et al. Human eosinophils release IL-1ss and 
increase expression of IL-17A in activated CD4+ T lymphocytes. Clin Exp Allergy 
2012; 42:1756-1764. 
18. Eckl-Dorna J, Ellinger A, Blatt K, et al. Basophils are not the key antigen-presenting cells 
in allergic patients. Allergy 2012; 67:601-608. 
19*. Otsuka A, Nakajima S, Kubo M, et al. Basophils are required for the induction of Th2 
immunity to haptens and peptide antigens. Nat Commun 2013; 4:1738. 
This is an important work that demonstrates that basophils alone can induce Th2-type immune 
responses for exposure to haptens or peptide antigens but must cooperate with PC cells for the 
induction Th2 for exposure to protein allergens. 
20. Sullivan BM, Liang HE, Bando JK, et al. Genetic analysis of basophil function in vivo. 
Nat Immunol  2011;  12:527-535. 
21. Wakahara K, Van VQ, Baba N, et al. Basophils are recruited to inflamed lungs and 
exacerbate memory Th2 responses in mice and humans. Allergy 2013; 68:180-189. 
22**. Egawa M, Mukai K, Yoshikawa S, et al. Inflammatory monocytes recruited to allergic 
skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. 
Immunity 2013; 38:570-580. 
This study reports how basophils drive the differentiation of inflammatory monocytes into M2 
(alternatively activated) macrophages thereby regulating allergic skin inflammation. 
19 
 
23. Han H, Headley MB, Xu W, et al. Thymic stromal lymphopoietin amplifies the 
differentiation of alternatively activated macrophages. J Immunol 2013; 190:904-912. 
24. Siracusa MC, Saenz SA, Hill DA, et al. TSLP promotes interleukin-3-independent 
basophil haematopoiesis and type 2 inflammation. RNA 2012; 477:229-233. 
25. Uhm TG, Kim BS, Chung IY. Eosinophil development, regulation of eosinophil-specific 
genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma 
Immunol Res 2012; 4:68-79. 
26*. Baba Y, Maeda K, Yashiro T, et al. Involvement of PU.1 in mast cell/basophil-specific 
function of the human IL1RL1/ST2 promoter. Allergol Int 2012; 61:461-467. 
The transcription factor PU.1 binds to the IL1R1/ST2 promoter and participates in its 
expression. 
27*. Matsuoka K, Shitara H, Taya C, et al. Novel basophil- or eosinophil-depleted mouse 
models for functional analyses of allergic inflammation. PLoS One 2013; 8:e60958. 
The two mouse models generated in this study clearly distinguish the in vivo functions of 
basophils and eosinophils in IgE-chronic Allergic Inflammation, providing a new approach 
for clarifying the role of these cells in allergic inflammation. 
28. Bouzigon E, Chaudru V, Carpentier AS, et al. Familial correlations and inter-relationships 
of four asthma-associated quantitative phenotypes in 320 French EGEA families 
ascertained through asthmatic probands. Eur J Hum Genet 2004; 12:955-963. 
29. Pilia G, Chen WM, Scuteri A, et al. Heritability of cardiovascular and personality traits in 
6,148 Sardinians. PLoS Genet 2006; 2:e132. 
30*. Kang M-J, Yu H-S, Seo J-H, et al. GSDMB/ORMDL3 variants contribute to asthma 
susceptibility and eosinophil-mediated bronchial hyperresponsiveness. Human 
Immunology 2012; 73:954-959. 
20 
 
This study replicates previous findings that identified a relationship between the 
GSDMB/ORMDL3-bearing locus, 17q12-21 and asthma, and suggests for the first time that 
GSDMB/ORMDL3 polymorphisms may shape the development of eosinophil-mediated 
bronchial hyperresponsiveness in Korean children from the general population. 
31. Takeuchi K, Mashimo Y, Shimojo N, et al. Functional variants in the thromboxane A2 
receptor gene are associated with lung function in childhood-onset asthma. Clin Exp 
Allergy 2013; 43:413-424. 
32. Ungvari I, Hadadi E, Virag V, et al. Implication of BIRC5 in asthma pathogenesis. Int 
Immunol 2012; 24:293-301. 
33. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil 
numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41:342-
347. 
34. Nalls MA, Couper DJ, Tanaka T, et al. Multiple loci are associated with white blood cell 
phenotypes. PLoS Genet 2011; 7:e1002113. 
35. Okada Y, Hirota T, Kamatani Y, et al. Identification of nine novel loci associated with 
white blood cell subtypes in a Japanese population. PLoS Genet 2011; 7:e1002067. 
36. Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with 
pediatric eosinophilic esophagitis. Nat Genet 2010; 42:289-291. 
 
 
Allergens 
IL33 TSLP IL25 
Mast cells 
Airway smooth muscle 
Dendritic cells 
Th2 cells 
Eosinophils Basophils  B cells 
Inflammatory mediators: Cytokines and chemokines 
IL10, IL4, IL5, IL9, IL13, IL17, GMCSF, TNFα	

Local inflammation 
Eosinophils 
recruitment 
Eosinophil recruitment 
cytokines:  IL2, IL3, IL4, 
IL5, IL9, IL13, IL33, TNFα	

IL1, IL4, IL5, IL13, GMCSF 
Histamine, LTB4, CCR3, TNFα	

IL4, IL19, IL25, IL33 IL3 - IL4 - IL13 
IL5, IL9, IL13, TNF 
Airway epithelial cells 
Blood  
vessel 
